Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Clinicoradiologic Criteria for the Diagnosis of Stroke-like Episodes in MELAS
Vadim Khasminsky1, Eitan Auriel1, Judith Luckman1
1From the Departments of Imaging (V.K., J.L., R.E., E.I.) and Neurology (E.A., K.P., R.B., M.M., J.N., S.P.), Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine (V.K., E.A., J.L., R.E., E.I., Y.L., R.B., S.P.), Tel Aviv University; Metabolic Diseases Clinic (Y.L.), Schneider Children's Medical Center, Petach Tikva; Department of Neurology (S.S.), Rambam Health Care Campus, Haifa, Israel; and Department of Neurology (S.S.), Mayo Clinic, Rochester, MN.
Background And Objectives:
Stroke-like episodes (SLEs) in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome are often misdiagnosed as acute ischemic stroke (AIS). We aimed to determine unique clinical and neuroimaging features for SLEs and formulate diagnostic criteria.
Methods:
We retrospectively identified patients with MELAS admitted for SLEs between January 2012 and December 2021. Clinical features and imaging findings were compared with a cohort of patients who presented with AIS and similar lesion topography. A set of criteria was formulated and then tested by a blinded rater to evaluate diagnostic performance.
Results:
Eleven MELAS patients with 17 SLE and 21 AISs were included. Patients with SLEs were younger (median 45 [37-60] vs 77 [68-82] years, p < 0.01) and had a lower body mass index (18 ± 2.6 vs 29 ± 4, p < 0.01), more commonly reported hearing loss (91% vs 5%, p < 0.01), and more commonly presented with headache and/or seizures (41% vs 0%, p < 0.01). The earliest neuroimaging test performed at presentation was uniformly a noncontrast CT. Two main patterns of lesion topography with a stereotypical spatiotemporal evolution were identified-an anterior pattern (7/21, 41%) starting at the temporal operculum and spreading to the peripheral frontal cortex and a posterior pattern (10/21, 59%) starting at the cuneus/precuneus and spreading to the lateral occipital and parietal cortex. Other distinguishing features for SLEs vs AIS were cerebellar atrophy (91% vs 19%, p < 0.01), previous cortical lesions with typical SLE distribution (46% vs 9%, p = 0.03), acute lesion tissue hyperemia and venous engorgement on CT angiography (CTA) (45% vs 0%, p < 0.01), and no large vessel occlusion on CTA (0% vs 100%, p < 0.01). Based on these clinicoradiologic features, a set of diagnostic criteria were constructed for possible SLE (sensitivity 100%, specificity 81%, AUC 0.905) and probable SLE (sensitivity 88%, specificity 95%, AUC 0.917).
Discussion:
Clinicoradiologic criteria based on simple anamnesis and a CT scan at presentation can accurately diagnose SLE and lead to early administration of appropriate therapy.
Classification Of Evidence:
This study provides Class III evidence that an algorithm using clinical and imaging features can differentiate stroke-like episodes due to MELAS from acute ischemic strokes.
Insights
Stroke-like episodes (SLEs) in MELAS patients are often misdiagnosed. New criteria using clinical and imaging features accurately differentiate SLEs from acute ischemic strokes (AIS), enabling timely treatment.
Area of Science:
- Neurology
- Mitochondrial Diseases
- Neuroimaging
Background:
- Stroke-like episodes (SLEs) in MELAS syndrome are frequently misdiagnosed as acute ischemic stroke (AIS).
- Distinguishing between SLEs and AIS is crucial for appropriate patient management.
- Unique clinical and neuroimaging features of SLEs in MELAS patients require elucidation.
Purpose of the Study:
- To identify distinct clinical and neuroimaging characteristics of SLEs in MELAS syndrome.
- To develop and validate diagnostic criteria for differentiating SLEs from AIS.
Main Methods:
- Retrospective analysis of MELAS patients with SLEs and a comparison cohort with AIS.
- Comparison of clinical features, including age, BMI, hearing loss, headache, and seizures.
- Analysis of neuroimaging findings, including lesion topography, cerebellar atrophy, and vascular imaging (CTA).
Main Results:
- MELAS patients with SLEs were younger, had lower BMI, and more frequently reported hearing loss, headache, and seizures compared to AIS patients.
- Distinct neuroimaging patterns were observed, including anterior and posterior lesion progressions, cerebellar atrophy, and hyperemia/venous engorgement on CTA without large vessel occlusion.
- Developed diagnostic criteria demonstrated high sensitivity and specificity for identifying possible and probable SLEs.
Conclusions:
- Clinicoradiologic criteria derived from patient history and CT scans can accurately diagnose SLEs in MELAS syndrome.
- Early and accurate diagnosis facilitates prompt administration of appropriate therapies.
- This study provides Class III evidence for an algorithm differentiating MELAS-related SLEs from AIS.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
05:12Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
Published on: September 19, 2019
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests